Caption Management’s RAPT Therapeutics RAPT Stock Holding History

Caption Management’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-8,931	Closed	-$113K	–	1771
2024 Q3	$144K	Sell	8,931 -4,788	-35%	-$96.8K	﹤0.01%	1095
2024 Q2	$335K	Hold	13,719	–	–	0.01%	884
2024 Q1	$986K	Buy	13,719 +7,306	+114%	+$1.02M	0.02%	740
2023 Q4	$1.27M	Buy	+6,413	New	+$794K	0.02%	746
2022 Q1	–	Sell	-3,750	Closed	-$1.1M	–	1855
2021 Q4	$1.1M	Buy	+3,750	New	+$1M	0.01%	1015
2021 Q3	–	Sell	-52,607	Closed	-$13.9M	–	1747
2021 Q2	$13.4M	Buy	+52,607	New	+$9.83M	0.17%	141

Caption Management's RAPT Position: Q4 2024 in Review

Caption Management sold out of RAPT Therapeutics (RAPT) in Q4 2024, closing a stake of 8,931 shares — an estimated $113K sold.

Caption Management first reported a position in RAPT in Q2 2021 and held it in 6 quarters. The position peaked at $13.4M in Q2 2021. 91 funds tracked by Wall St. Rank hold RAPT as of Q4 2024.

Caption Management reported no remaining RAPT Therapeutics position as of Q4 2024 after selling out during the quarter.
Caption Management sold 8,931 RAPT Therapeutics shares in Q4 2024, an estimated $113K.
Caption Management first reported a position in RAPT Therapeutics in Q2 2021 and held it in 6 quarters.
Caption Management's RAPT Therapeutics position peaked at $13.4M in Q2 2021.
91 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q4 2024.

Based on Caption Management's 13F filing for Q4 2024, filed 14 Feb 2025.